Yong Ai

862 total citations
31 papers, 664 citations indexed

About

Yong Ai is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Yong Ai has authored 31 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Yong Ai's work include Synthesis and biological activity (5 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Cancer therapeutics and mechanisms (3 papers). Yong Ai is often cited by papers focused on Synthesis and biological activity (5 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Cancer therapeutics and mechanisms (3 papers). Yong Ai collaborates with scholars based in China and United States. Yong Ai's co-authors include Fengtian Xue, Chong Sun, Xiantao Cai, Jun Tie, Yihua Zhang, Fenghua Kang, Zhangjian Huang, Jide Tian, Sixun Peng and Yisheng Lai and has published in prestigious journals such as Journal of Virology, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Yong Ai

31 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yong Ai China 16 290 165 110 83 58 31 664
Morteza Ghandadi Iran 14 332 1.1× 189 1.1× 66 0.6× 95 1.1× 74 1.3× 30 763
Kamila Środa-Pomianek Poland 15 405 1.4× 71 0.4× 116 1.1× 133 1.6× 74 1.3× 41 741
Malek Zihlif Jordan 15 297 1.0× 120 0.7× 56 0.5× 125 1.5× 62 1.1× 78 742
Anna Lichota Poland 9 253 0.9× 100 0.6× 101 0.9× 33 0.4× 73 1.3× 14 634
Lenka Varinská Slovakia 17 431 1.5× 234 1.4× 136 1.2× 85 1.0× 131 2.3× 28 968
Joomin Lee South Korea 19 336 1.2× 69 0.4× 119 1.1× 124 1.5× 69 1.2× 47 1.0k
Veronika Hanušová Czechia 16 406 1.4× 79 0.5× 88 0.8× 120 1.4× 54 0.9× 28 769
Wen Tan China 16 461 1.6× 133 0.8× 84 0.8× 96 1.2× 123 2.1× 32 877
Mohamed R. Akl United States 17 370 1.3× 188 1.1× 108 1.0× 114 1.4× 102 1.8× 23 862
Heying Pei China 18 427 1.5× 289 1.8× 74 0.7× 150 1.8× 83 1.4× 56 935

Countries citing papers authored by Yong Ai

Since Specialization
Citations

This map shows the geographic impact of Yong Ai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Ai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Ai more than expected).

Fields of papers citing papers by Yong Ai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Ai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Ai. The network helps show where Yong Ai may publish in the future.

Co-authorship network of co-authors of Yong Ai

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Ai. A scholar is included among the top collaborators of Yong Ai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Ai. Yong Ai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Minghui, Yong Ai, Song Ni, et al.. (2023). Chemical Composition and Hypnotic Effect of Picea mariana Essential Oils. Journal of Essential Oil Bearing Plants. 26(2). 362–377. 5 indexed citations
2.
Wu, Shijia, Yong Ai, Huimin Huang, et al.. (2022). A synthesized olean-28,13β-lactam targets YTHDF1-GLS1 axis to induce ROS-dependent metabolic crisis and cell death in pancreatic adenocarcinoma. Cancer Cell International. 22(1). 143–143. 8 indexed citations
3.
Ai, Yong, Srilatha Sakamuru, Greg H. Imler, Menghang Xia, & Fengtian Xue. (2022). Improving the solubility and antileukemia activity of Wnt/β-catenin signaling inhibitors by disrupting molecular planarity. Bioorganic & Medicinal Chemistry. 69. 116890–116890. 2 indexed citations
4.
Lu, Yong‐Jie, et al.. (2021). Glabridin Liposome Ameliorating UVB-Induced Erythema and Lethery Skin by Suppressing Inflammatory Cytokine Production. Journal of Microbiology and Biotechnology. 31(4). 630–636. 14 indexed citations
5.
Ai, Yong, et al.. (2021). Progress toward B-Cell Lymphoma 6 BTB Domain Inhibitors for the Treatment of Diffuse Large B-Cell Lymphoma and Beyond. Journal of Medicinal Chemistry. 64(8). 4333–4358. 18 indexed citations
6.
Zhang, Bing, Minghui Tang, Yong Ai, et al.. (2020). Chemical composition of Blumea balsamifera and Magnolia sieboldii essential oils and prevention of UV-B radiation-induced skin photoaging. Natural Product Research. 35(24). 5977–5980. 15 indexed citations
7.
Liang, Dongdong, Linhao Li, Caitlin Lynch, et al.. (2019). Human constitutive androstane receptor agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapies. European Journal of Medicinal Chemistry. 179. 84–99. 11 indexed citations
8.
Cai, Yanhui, Fengtian Xue, Yong Ai, et al.. (2019). BCL6 BTB‐specific inhibition via FX1 treatment reduces Tfh cells and reverses lymphoid follicle hyperplasia in Indian rhesus macaque (Macaca mulatta). Journal of Medical Primatology. 49(1). 26–33. 8 indexed citations
9.
Ai, Yong, Yingjun Li, Wei Yang, et al.. (2019). Triazole-Based Inhibitors of the Wnt/β-Catenin Signaling Pathway Improve Glucose and Lipid Metabolisms in Diet-Induced Obese Mice. Journal of Medicinal Chemistry. 62(2). 727–741. 20 indexed citations
10.
Zhu, Bin, Caiping Ren, Ke Du, et al.. (2019). Olean-28,13b-olide 2 plays a role in cisplatin-mediated apoptosis and reverses cisplatin resistance in human lung cancer through multiple signaling pathways. Biochemical Pharmacology. 170. 113642–113642. 28 indexed citations
11.
Yang, Wei, Yingjun Li, Yong Ai, et al.. (2019). Pyrazole-4-Carboxamide (YW2065): A Therapeutic Candidate for Colorectal Cancer via Dual Activities of Wnt/β-Catenin Signaling Inhibition and AMP-Activated Protein Kinase (AMPK) Activation. Journal of Medicinal Chemistry. 62(24). 11151–11164. 33 indexed citations
12.
Cheng, Huimin, Brian M. Linhares, Wenbo Yu, et al.. (2018). Identification of Thiourea-Based Inhibitors of the B-Cell Lymphoma 6 BTB Domain via NMR-Based Fragment Screening and Computer-Aided Drug Design. Journal of Medicinal Chemistry. 61(17). 7573–7588. 29 indexed citations
13.
Ai, Yong, et al.. (2018). Enhanced Tumor Selectivity of 5-Fluorouracil Using a Reactive Oxygen Species-Activated Prodrug Approach. ACS Medicinal Chemistry Letters. 10(1). 127–131. 28 indexed citations
14.
Zhang, Hong, Da‐Wei Gong, Liqiang Ni, et al.. (2018). Serum Elabela/Toddler Levels Are Associated with Albuminuria in Patients with Type 2 Diabetes. Cellular Physiology and Biochemistry. 48(3). 1347–1354. 29 indexed citations
15.
Lu, Shan, et al.. (2018). Novel cinnamaldehyde-based aspirin derivatives for the treatment of colorectal cancer. Bioorganic & Medicinal Chemistry Letters. 28(17). 2869–2874. 12 indexed citations
16.
Kang, Fenghua, Yong Ai, Yihua Zhang, & Zhangjian Huang. (2018). Design and synthesis of new hybrids from 2-cyano-3,12-dioxooleana- 9-dien-28-oic acid and O 2 -(2,4-dinitrophenyl) diazeniumdiolate for intervention of drug-resistant lung cancer. European Journal of Medicinal Chemistry. 149. 269–280. 20 indexed citations
17.
Lan, Linhua, Miaomiao Guo, Yong Ai, et al.. (2017). Tetramethylpyrazine blocks TFAM degradation and up-regulates mitochondrial DNA copy number by interacting with TFAM. Bioscience Reports. 37(3). 23 indexed citations
18.
Ai, Yong, Fenghua Kang, Zhangjian Huang, et al.. (2015). Synthesis of CDDO–Amino Acid–Nitric Oxide Donor Trihybrids as Potential Antitumor Agents against Both Drug-Sensitive and Drug-Resistant Colon Cancer. Journal of Medicinal Chemistry. 58(5). 2452–2464. 62 indexed citations
19.
Ai, Yong, et al.. (2011). Combined 3D-QSAR Modeling and Molecular Docking Studies on Pyrrole-Indolin-2-ones as Aurora A Kinase Inhibitors. International Journal of Molecular Sciences. 12(3). 1605–1624. 14 indexed citations
20.
Ai, Yong, et al.. (2010). 3D-QSAR and docking studies on pyridopyrazinones as BRAF inhibitors. Medicinal Chemistry Research. 20(8). 1298–1317. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Morteza Ghandadi Breakdown of academic impact, for papers by Kamila Środa-Pomianek Breakdown of academic impact, for papers by Malek Zihlif Breakdown of academic impact, for papers by Anna Lichota Breakdown of academic impact, for papers by Lenka Varinská Breakdown of academic impact, for papers by Joomin Lee Breakdown of academic impact, for papers by Veronika Hanušová Breakdown of academic impact, for papers by Wen Tan Breakdown of academic impact, for papers by Mohamed R. Akl Breakdown of academic impact, for papers by Heying Pei
Rankless by CCL
2026